简介：【摘要】目的 对冠脉支架介入治疗冠心病的预后及影响因素进行探究。 方法 选取2020年3月至2021年5月期间本院收治的冠心病患者84例，对患者进行为期2年的随访并对其临床资料进行回顾性分析。结果 随访中，不良心脏事件发生率为17.86%，不良心脏事件的危险因素包括残余狭隘、心绞痛复发、糖尿病、再狭窄者、新发病变、非致命性心肌梗以及其他危险因素等。结论 了解并掌握影响冠心病支架介入治疗的相关因素，能够及时采取具有针对性的干预措施预防并应对危险因素，使得预后被有效改善。

简介：　　摘要：目的 观察心脉隆联合比索洛尔对冠心病合并心衰患者血清炎症因子及心功能的影响。方法 选择 2015年 11月至 2017年 2月我院收治的冠心病合并心衰患者 88例，根据就诊顺序分为对照组 44例和试验组 44例。对照组应用比索洛尔口服进行治疗，试验组应用心脉隆 +比索洛尔进行联合治疗。观察两组治疗效果。结果 治疗后，对照组超敏 C反应蛋白（ hypersensitive C-reactive protein， hs-CRP）、 B型利钠肽（ Brain natriuretic peptide， BNP）、左室射血分数（ Left Ventricular Ejection Fractions， LVEF）水平均低于试验组，左心室收缩末期容积（ left ventricular end-systolic volume， LVESV）及左心室舒张末期容积（ left ventricular end-diastolic volume， LVEDV）水平高于试验组，差异有统计学意义（ P<0.05）。结论 在冠心病合并心衰患者中应用心脉隆与比索洛尔联合治疗可有效改善炎症因子水平，增强心功能。  　　关键词：冠心病合并心衰 ;心脉隆 ;比索洛尔 ;血清炎症因子 ;心功能  　 ABSTRACT: Objective To observe the effect of Xinmailong combined with bisoprolol on serum inflammatory factors and cardiac function in patients with coronary heart disease and heart failure. Methods From November 2015 to February 2017, 88 patients with coronary heart disease and heart failure were selected and divided into control group (44 cases) and experimental group (44 cases). The control group was treated with bisoprolol orally, and the experimental group was treated with cardiopulmonary bypass plus bisoprolol. The therapeutic effects of the two groups were observed. Results After treatment, the levels of hypersensitive C-reactive protein (hs-CRP), B-type natriuretic peptide (BNP), left ventricular ejection fractions (LVEF) in the control group were lower than those in the experimental group, and left ventricular end-systolic volume (LVESV) and left ventricular end-diastolic volume (LVDV) were lower than those in the control group. The level of left ventricular end-diastolic volume (LVEDV) was higher than that of the experimental group (P < 0.05). Conclusion The combination therapy of cardiopulmonary bypass and bisoprolol can effectively improve the level of inflammatory factors and enhance cardiac function in patients with coronary heart disease and heart failure.